01 1Meiji Seika Pharma
01 1DOXORUBICIN HYDROCHLORIDE DRUG SUBSTANCE
01 1Japan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-10-18
Pay. Date : 2015-12-28
DMF Number : 13209
Submission : 1998-04-30
Status : Active
Type : II
20
Meiji Seika Pharma Co Ltd, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXORUBICIN HYDROCHLORIDE DRUG SUBSTANCE, with a corresponding US DMF Number 13209.
Remarkably, this DMF maintains an Active status since its submission on April 30, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 18, 2017, and payment made on December 28, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
